首页 > 最新文献

Current hepatitis reports最新文献

英文 中文
The Role of Micronutrients in Chronic Liver Disease 微量营养素在慢性肝病中的作用
Pub Date : 2023-06-22 DOI: 10.1007/s11901-023-00605-8
Bassem Ibrahim, Dhanashree Tikhe, S. Bollipo
{"title":"The Role of Micronutrients in Chronic Liver Disease","authors":"Bassem Ibrahim, Dhanashree Tikhe, S. Bollipo","doi":"10.1007/s11901-023-00605-8","DOIUrl":"https://doi.org/10.1007/s11901-023-00605-8","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"216 - 220"},"PeriodicalIF":0.0,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45145400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Immune-Tolerant Patients with Chronic HBV Infection 慢性HBV感染免疫耐受患者的管理
Pub Date : 2023-06-09 DOI: 10.1007/s11901-023-00604-9
T. Tseng, Hung-Yao Lin, J. Kao
{"title":"Management of Immune-Tolerant Patients with Chronic HBV Infection","authors":"T. Tseng, Hung-Yao Lin, J. Kao","doi":"10.1007/s11901-023-00604-9","DOIUrl":"https://doi.org/10.1007/s11901-023-00604-9","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"130 - 137"},"PeriodicalIF":0.0,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43103012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extrahepatic Manifestations of Hepatitis B 乙型肝炎肝外表现
Pub Date : 2023-05-24 DOI: 10.1007/s11901-023-00603-w
N. Najafian, Steven‐Huy B. Han
{"title":"Extrahepatic Manifestations of Hepatitis B","authors":"N. Najafian, Steven‐Huy B. Han","doi":"10.1007/s11901-023-00603-w","DOIUrl":"https://doi.org/10.1007/s11901-023-00603-w","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"147 - 157"},"PeriodicalIF":0.0,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42211166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Nutrition in Preventing Liver Disease 营养在预防肝病中的作用
Pub Date : 2023-05-09 DOI: 10.1007/s11901-023-00602-x
Madeleine G Haff, A. Mohanty
{"title":"Role of Nutrition in Preventing Liver Disease","authors":"Madeleine G Haff, A. Mohanty","doi":"10.1007/s11901-023-00602-x","DOIUrl":"https://doi.org/10.1007/s11901-023-00602-x","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"74 - 81"},"PeriodicalIF":0.0,"publicationDate":"2023-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45930561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacotherapies for Portal Hypertension: Current Status and Expanding Indications. 门静脉高压的药物治疗:现状和扩大适应症
Pub Date : 2023-03-01 Epub Date: 2023-02-20 DOI: 10.1007/s11901-023-00600-z
Mohamed A Elfeki, Ashwani K Singal, Patrick S Kamath

Purpose: Non-selective beta blockers remain pharmacotherapy of choice for prevention of first episode of variceal bleeding (primary prevention) and for prevention of its recurrence after initial hemostasis (secondary prophylaxis). This review will update the current and emerging pharmacological therapies for portal hypertension.

Recent findings: Data have emerged on carvedilol in preventing hepatic decompensation and improving patient survival among patients with clinically significant portal hypertension. Because measurement of WHVP is invasive and not feasible in routine practice, non-invasive tests with liver stiffness measurement in combination with platelet count may be accurate in identifying clinically significant portal hypertension.

Summary: Carvedilol is more effective in reducing portal pressure compared to nadolol or propranolol. Its use has expanded to reduce risk of hepatic decompensation among patients with CSPH, which can be identified non-invasively using liver stiffness and platelet count. Studies are needed on non-invasive biomarkers to guide and optimize pharmacological treatment of portal hypertension.

目的:非选择性β受体阻滞剂仍是预防首次静脉曲张出血(一级预防)和预防首次止血后复发(二级预防)的首选药物疗法。本综述将介绍治疗门静脉高压症的最新药物疗法:有数据显示,卡维地洛可预防肝功能失代偿,并提高临床上门静脉高压症患者的生存率。由于WHVP的测量是侵入性的,在常规实践中并不可行,因此结合血小板计数进行肝脏硬度测量的非侵入性检测可能会准确识别临床上显著的门静脉高压。卡维地洛的使用范围已经扩大,以降低 CSPH 患者肝脏失代偿的风险,而肝脏僵硬度和血小板计数可以无创识别 CSPH。需要对非侵入性生物标志物进行研究,以指导和优化门静脉高压症的药物治疗。
{"title":"Pharmacotherapies for Portal Hypertension: Current Status and Expanding Indications.","authors":"Mohamed A Elfeki, Ashwani K Singal, Patrick S Kamath","doi":"10.1007/s11901-023-00600-z","DOIUrl":"10.1007/s11901-023-00600-z","url":null,"abstract":"<p><strong>Purpose: </strong>Non-selective beta blockers remain pharmacotherapy of choice for prevention of first episode of variceal bleeding (primary prevention) and for prevention of its recurrence after initial hemostasis (secondary prophylaxis). This review will update the current and emerging pharmacological therapies for portal hypertension.</p><p><strong>Recent findings: </strong>Data have emerged on carvedilol in preventing hepatic decompensation and improving patient survival among patients with clinically significant portal hypertension. Because measurement of WHVP is invasive and not feasible in routine practice, non-invasive tests with liver stiffness measurement in combination with platelet count may be accurate in identifying clinically significant portal hypertension.</p><p><strong>Summary: </strong>Carvedilol is more effective in reducing portal pressure compared to nadolol or propranolol. Its use has expanded to reduce risk of hepatic decompensation among patients with CSPH, which can be identified non-invasively using liver stiffness and platelet count. Studies are needed on non-invasive biomarkers to guide and optimize pharmacological treatment of portal hypertension.</p>","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"44-50"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10723787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45530842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease 非酒精性脂肪肝患者肝癌的风险分层
Pub Date : 2023-03-01 DOI: 10.1007/s11901-023-00595-7
Emily Truong, C. Han, M. Muthiah, M. Noureddin
{"title":"Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease","authors":"Emily Truong, C. Han, M. Muthiah, M. Noureddin","doi":"10.1007/s11901-023-00595-7","DOIUrl":"https://doi.org/10.1007/s11901-023-00595-7","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"1 - 8"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44425309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Gastric and Ectopic Varices 胃和异位静脉曲张的治疗
Pub Date : 2023-02-06 DOI: 10.1007/s11901-023-00597-5
C. Vashishtha, S. Sarin
{"title":"Management of Gastric and Ectopic Varices","authors":"C. Vashishtha, S. Sarin","doi":"10.1007/s11901-023-00597-5","DOIUrl":"https://doi.org/10.1007/s11901-023-00597-5","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"33 - 43"},"PeriodicalIF":0.0,"publicationDate":"2023-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48391153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary Management of Metabolic Liver Disease 代谢性肝病的饮食管理
Pub Date : 2023-02-02 DOI: 10.1007/s11901-023-00599-3
Tanyaporn K Kaenkumchorn, Shreena Patel, Esther Berenhaut, Rohit Kohli
{"title":"Dietary Management of Metabolic Liver Disease","authors":"Tanyaporn K Kaenkumchorn, Shreena Patel, Esther Berenhaut, Rohit Kohli","doi":"10.1007/s11901-023-00599-3","DOIUrl":"https://doi.org/10.1007/s11901-023-00599-3","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"22 1","pages":"24 - 32"},"PeriodicalIF":0.0,"publicationDate":"2023-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41916766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Nutrition in Viral Hepatitis 病毒性肝炎的营养
Pub Date : 2023-01-20 DOI: 10.1007/s11901-023-00596-6
D. Praharaj, A. Anand
{"title":"Nutrition in Viral Hepatitis","authors":"D. Praharaj, A. Anand","doi":"10.1007/s11901-023-00596-6","DOIUrl":"https://doi.org/10.1007/s11901-023-00596-6","url":null,"abstract":"","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"1 1","pages":"1-15"},"PeriodicalIF":0.0,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44711729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Sellar masses: diagnosis and treatment. Sellar 肿块:诊断和治疗。
Pub Date : 2022-11-24 eCollection Date: 2022-01-01 DOI: 10.3389/fopht.2022.970580
Dana Al-Bader, Alya Hasan, Raed Behbehani

Sellar mases can cause a variety of neuro-ophthalmic manifestations, including compressive optic neuropathy, chiasmal syndrome, and ophthalmoplegia due to cranial nerve palsy. Diagnosis involves a thorough history, neuro-ophthalmic examination, and ancillary tests and investigations. Visual field testing is critical in diagnosing and localizing the lesion and determining the extent of visual field loss. Appropriate neuro-imaging is essential in characterizing and localizing the lesion. Neuro-ophthalmologic assessment include meticulous clinical examination and ancillary tests including,visual field testing, which is useful in localizing the lesion, and optical coherence tomography, which is helpful in assessing the degree of axonal and neuronal loss and predicting the visual outcome. Treatment requires a multidisciplinary approach by different specialties, including radiologists, neuro-ophthalmologists, and neurosurgeons. The two primary treatment modalities for these tumors are surgery and radiation therapy. We review the main types of sellar lesions, their neuro-ophthalmologic evaluation, and treatment options.

塞拉氏病可引起多种神经眼科表现,包括压迫性视神经病变、椎体综合征和颅神经麻痹引起的眼球震颤。诊断需要详尽的病史、神经眼科检查以及辅助测试和检查。视野测试对于诊断和定位病变以及确定视野缺损的程度至关重要。适当的神经影像学检查对于确定病变的特征和定位至关重要。神经眼科评估包括细致的临床检查和辅助检查,其中包括有助于定位病变的视野检测和有助于评估轴突和神经元缺失程度并预测视觉结果的光学相干断层扫描。治疗需要放射科医生、神经眼科医生和神经外科医生等不同专业的多学科协作。这些肿瘤的两种主要治疗方式是手术和放射治疗。我们将回顾蝶窦病变的主要类型、其神经眼科评估和治疗方案。
{"title":"Sellar masses: diagnosis and treatment.","authors":"Dana Al-Bader, Alya Hasan, Raed Behbehani","doi":"10.3389/fopht.2022.970580","DOIUrl":"10.3389/fopht.2022.970580","url":null,"abstract":"<p><p>Sellar mases can cause a variety of neuro-ophthalmic manifestations, including compressive optic neuropathy, chiasmal syndrome, and ophthalmoplegia due to cranial nerve palsy. Diagnosis involves a thorough history, neuro-ophthalmic examination, and ancillary tests and investigations. Visual field testing is critical in diagnosing and localizing the lesion and determining the extent of visual field loss. Appropriate neuro-imaging is essential in characterizing and localizing the lesion. Neuro-ophthalmologic assessment include meticulous clinical examination and ancillary tests including,visual field testing, which is useful in localizing the lesion, and optical coherence tomography, which is helpful in assessing the degree of axonal and neuronal loss and predicting the visual outcome. Treatment requires a multidisciplinary approach by different specialties, including radiologists, neuro-ophthalmologists, and neurosurgeons. The two primary treatment modalities for these tumors are surgery and radiation therapy. We review the main types of sellar lesions, their neuro-ophthalmologic evaluation, and treatment options.</p>","PeriodicalId":88466,"journal":{"name":"Current hepatitis reports","volume":"14 1","pages":"970580"},"PeriodicalIF":0.0,"publicationDate":"2022-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74794241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current hepatitis reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1